| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.045 | 0.8 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.046 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.03 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |